HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway.

AbstractAIMS:
On the basis of our previous reports that cardioprotection induced by ischaemic preconditioning induces autophagy and that resveratrol, a polyphenolic antioxidant present in grapes and red wine induces preconditioning-like effects, we sought to determine if resveratrol could induce autophagy.
METHODS AND RESULTS:
Resveratrol at lower doses (0.1 and 1 microM in H9c2 cardiac myoblast cells and 2.5 mg/kg/day in rats) induced cardiac autophagy shown by enhanced formation of autophagosomes and its component LC3-II after hypoxia-reoxygenation or ischaemia-reperfusion. The autophagy was attenuated with the higher dose of resveratrol. The induction of autophagy was correlated with enhanced cell survival and decreased apoptosis. Treatment with rapamycin (100 nM), a known inducer of autophagy, did not further increase autophagy compared with resveratrol alone. Autophagic inhibitors, wortmannin (2 microM) and 3-methyladenine (10 mM), significantly attenuated the resveratrol-induced autophagy and induced cell death. The activation of mammalian target of rapamycin (mTOR) was differentially regulated by low-dose resveratrol, i.e. the phosphorylation of mTOR at serine 2448 was inhibited, whereas the phosphorylation of mTOR at serine 2481 was increased, which was attenuated with a higher dose of resveratrol. Although resveratrol attenuated the activation of mTOR complex 1, low-dose resveratrol significantly induced the expression of Rictor, a component of mTOR complex 2, and activated its downstream survival kinase Akt (Ser 473). Resveratrol-induced Rictor was found to bind with mTOR. Furthermore, treatment with Rictor siRNA attenuated the resveratrol-induced autophagy.
CONCLUSION:
Our results indicate that at lower dose, resveratrol-mediated cell survival is, in part, mediated through the induction of autophagy involving the mTOR-Rictor survival pathway.
AuthorsNarasimman Gurusamy, Istvan Lekli, Subhendu Mukherjee, Diptarka Ray, Md Kaimul Ahsan, Mihaela Gherghiceanu, Lawrence M Popescu, Dipak K Das
JournalCardiovascular research (Cardiovasc Res) Vol. 86 Issue 1 Pg. 103-12 (Apr 01 2010) ISSN: 1755-3245 [Electronic] England
PMID19959541 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cardiotonic Agents
  • Carrier Proteins
  • Crtc1 protein, rat
  • Intracellular Signaling Peptides and Proteins
  • Rapamycin-Insensitive Companion of mTOR Protein
  • Stilbenes
  • Transcription Factors
  • rictor protein, rat
  • mTOR protein, rat
  • Protein Serine-Threonine Kinases
  • TOR Serine-Threonine Kinases
  • Resveratrol
Topics
  • Animals
  • Apoptosis (drug effects)
  • Autophagy (drug effects, physiology)
  • Cardiotonic Agents (pharmacology)
  • Carrier Proteins (metabolism)
  • Cell Line
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • Male
  • Myoblasts, Cardiac (cytology, drug effects, metabolism)
  • Myocardium (cytology)
  • Phosphorylation (drug effects)
  • Protein Serine-Threonine Kinases (metabolism)
  • Rapamycin-Insensitive Companion of mTOR Protein
  • Rats
  • Rats, Sprague-Dawley
  • Resveratrol
  • Stilbenes (pharmacology)
  • TOR Serine-Threonine Kinases
  • Transcription Factors (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: